30.9 F
New York
November 30, 2021

PHAR1

Biden told it will take two weeks to have definitive data on Omicron variant

Reuters
WASHINGTON, Nov 28 (Reuters) – The top U.S. infectious disease official, Dr. Anthony Fauci, told President Joe Biden on Sunday it will take about two weeks to have definitive information on the new coronavirus variant Omicron that has sparked new travel restrictions and shaken financial markets. Biden, returning to Washington......

Novavax developing vaccine that targets new COVID-19 variant

Reuters
A woman holds a small bottle labeled with a “Coronavirus COVID-19 Vaccine” sticker and a medical syringe in front of displayed Novavax logo in this illustration taken, October 30, 2020. REUTERS/Dado Ruvic Register now for FREE unlimited access to reuters.com Register Nov 26 (Reuters) – Novavax Inc (NVAX.O) said on......

Merck’s COVID-19 pill significantly less effective in new analysis

Reuters
An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters on October 26, 2021. Merck & Co Inc/Handout via REUTERS Register now for FREE......

Pfizer/BioNTech expect data on shot’s protection against new COVID-19 variant soon

Reuters
Looking for signs that warrant a vaccine redesign BioNTech says it understands experts’ concerns BioNTech, Pfizer in effort to establish relaunch routine FRANKFURT, Nov 26 (Reuters) – BioNTech SE (22UAy.DE) said on Friday it expects more data on a worrying new coronavirus variant detected in South Africa within two weeks......

EU drug regulator approves first COVID shot for 5-11 year olds

Reuters
A health worker receives a dose of the Pfizer-BioNTech COVID-19 vaccine in Madrid, Spain, February 4, 2021. REUTERS/Sergio Perez Register now for FREE unlimited access to reuters.com Register Nov 25 (Reuters) – The EU’s drug regulator approved the use of Pfizer-BioNTech’s COVID-19 vaccine for children between the ages of five......

GSK ties up with Arrowhead to develop NASH drug candidate

Reuters
A GlaxoSmithKline (GSK) logo is seen at the GSK research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls Nov 22 (Reuters) – Arrowhead Pharmaceuticals Inc (ARWR.O) on Monday entered a drug development deal with GlaxoSmithKline Plc (GSK.L) under which the British drugmaker will develop and market Arrowhead’s potential treatment......

CDC panel backs expanding COVID-19 booster eligibility to all U.S. adults

Reuters
Nov 19 (Reuters) – Advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Friday recommended expanding eligibility of COVID-19 vaccine booster shots to all adults in the United States, which would pave the way for millions more Americans to get additional protection against the virus. Earlier on......

EQT, BioNTech investor consider bid for Novartis arm Sandoz -report

Reuters
A general view of the BioNTech building where the production of the coronavirus disease (COVID-19) vaccine has started in Marburg, Germany, November 18, 2021. REUTERS/Fabian Bimmer Register now for FREE unlimited access to reuters.com Register ZURICH, Nov 19 (Reuters) – Investment group EQT and the Struengmann family, who are investors......

EU regulator begins review of Pfizer’s COVID-19 pill

Reuters
A company logo is seen through branches at a Pfizer office in Dublin, Ireland November 24, 2015. REUTERS/Cathal McNaughton Register now for FREE unlimited access to reuters.com Register Review to aid EU states with early emergency use Real-time rolling review of pill, Paxlovid, anticipated EU in talks with Pfizer over......

AstraZeneca’s preventative COVID-19 shot shown to work longer-term

Reuters
The logo for AstraZeneca is seen outside its North America headquarters in Wilmington, Delaware, U.S., March 22, 2021. REUTERS/Rachel Wisniewski AZD7442 offers 83% protection over 6 months vs 77% over 3 months Drug cut risk of severe COVID by 88% if given in first 3 days Offers options for those......

U.S. plans to invest billions in manufacturing COVID-19 vaccine

Reuters
A nurses fills up syringes for patients as they receive their coronavirus disease (COVID-19) booster vaccination during a Pfizer-BioNTech vaccination clinic in Southfield, Michigan, U.S., September 29, 2021. REUTERS/Emily Elconin WASHINGTON, Nov 17 (Reuters) – The United States plans to invest billions of dollars in expanding COVID-19 vaccine manufacturing capacity......

Analysis: Banks profit from building up and breaking up companies

Reuters
Nov 16 (Reuters) – It is a constant dilemma facing companies; do they acquire or shed businesses to boost shareholder returns? Investment bankers profit every time the answer involves a deal, even if it represents an about-face for the companies. Last week’s announcements by General Electric Co (GE.N), Toshiba Corp......

Nigeria plans mass vaccination drive, considers booster shot

Reuters
ABUJA, Nov 15 (Reuters) – Nigeria will start a mass COVID-19 vaccination campaign later this week, aiming to inoculate half of its targeted population by the end of January, government officials said. Africa’s most-populous country has a goal to vaccinate 111 million people to reach herd immunity. Under the initiative......

Washington state, in $95 billion opioid trial, blames drug distributors for crisis

Reuters
Nov 15 (Reuters) – Washington state’s attorney general on Monday argued that three large drug distributors’ excessive shipments of pain pills helped create the U.S. opioid epidemic, calling it the “worst man-made public health crisis in history,” at the start of a trial seeking $95 billion from the companies. Washington......

Austria locks down unvaccinated as COVID cases surge across Europe

Reuters
Austrian lockdown for unvaccinated hard to police Europe again becomes epicentre of pandemic Austrian anti-vaxxer tests positive for COVID-19 British PM sees ‘storm of infection’ in parts of Europe VIENNA, Nov 15 (Reuters) – Austria imposed a lockdown on people unvaccinated against the coronavirus on Monday as winter approaches and......

Some states expand booster availability beyond federal recommendations

Reuters
CHICAGO, Nov 12 (Reuters) – Hard hit by rising cases and hospitalizations, officials in Colorado and California this week have directed healthcare providers to make COVID-19 vaccine boosters available to all adults, overriding more restrictive guidance from the U.S. Centers for Disease Control and Prevention (CDC). “I think it is......

Johnson & Johnson to split into two to focus on drugs

Reuters
Nov 12 (Reuters) – Johnson & Johnson (JNJ.N) plans to spin off its consumer health division that sells Listerine and Baby Powder to focus on pharmaceuticals and medical devices in the biggest shake-up in the U.S. company’s 135-year history. The move by the world’s largest health products company comes hot......

AstraZeneca vaccine turns profitable, drugmaker banking on new orders

Reuters
Vaccine adds one cent to Q3 EPS Co expects profit from shot to offset antibody costs Q3 sales jump 47%, but costs bite 2021 sales outlook improved, profit maintained Shares down 2.4% Nov 12 (Reuters) – AstraZeneca (AZN.L) is counting on new orders to move its COVID-19 vaccine to “modest......

Story containing dated news about EU update on J&J COVID-19 vaccine withdrawn

Reuters
Nov 11 (Reuters) – The Nov. 11 story headlined “EU lists rare spinal condition as side-effect of J&J COVID-19 shot” is withdrawn. The story was based on a European Medicines Agency statement from Oct. 6 and was issued inadvertently. The UPDATE 1 and first version of the story are both......

Pfizer seeks FDA nod for COVID vaccine boosters for U.S. adults

Reuters
Nov 9 (Reuters) – Pfizer Inc (PFE.N) and BioNTech on Tuesday requested the U.S. Food and Drug Administration (FDA) to authorize booster doses of their COVID-19 vaccine in all adults, presenting recent data showing the shot would help prevent disease across ages. Over the past several months, the FDA has......

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Click whichever is suitable. Accept Read More